Baer Law Blog - Latest Updates
Empowering Pharmacists in the Fight Against Opioid Abuse Act
Yesterday, President Trump signed into law the “Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for…
SUPPORT for Patients and Communities Act
Yesterday, on the one-year anniversary of declaring a national opioid public health emergency, President Trump signed into…
Analyzing Colorado Pharmacist 2014 Disciplinary Actions: Controlled Substances, Red Flags and Pharmacist Corresponding Responsibility
Baer Law recently completed an analysis of thirty-three (33) separate 2014 disciplinary cases against Colorado pharmacists by…
Epidiolex (Cannabidiol) is a Schedule V Controlled Substance
Yesterday, the Drug Enforcement Administration announced that Epidiolex, which contains cannabidiol (CBD), a chemical constituent of the…
FDA and Responsible Opioid Prescribing for Pain Management in Animals
The Food and Drug Administration (FDA) continues to address the opioid epidemic on all fronts with regards…
Opioid Crisis Response Act Passed By Senate
Yesterday, the US Senate passed an opioid bill – The Opioid Crisis Response Act – that addresses illicit…
Colorado Limits Access to Products with Dextromethorphan
On August 8, 2018, House Bill 18-1307, which limits access to products with dextromethorphan, went into effect….
FDA’s Efforts to Advance Antimicrobial Stewardship in Veterinary Settings
Antimicrobial drugs, when used correctly, fight infections, but when antimicrobials are overused or misused, they promote antimicrobial…
Oklahoma Board of Pharmacy Fires Executive Director
The Oklahoma Board of Pharmacy fired its Executive Director, Chelsea Church, after state investigators acknowledged Church is…
OK Board of Health Votes to Ban Sales of Smokeable Marijuana
Earlier this week, Oklahoma Governor Mary Fallin signed the emergency rules on a medical marijuana program that…